| Financial Year |
March 31 2023 |
| Monetary Funds |
28,620,504,000.00 |
| Held-for-trading Financial Assets |
8,033,179,000.00 |
| Notes Receivable |
5,185,166,000.00 |
| Accounts Receivable |
39,727,115,000.00 |
| Advances to Suppliers |
11,111,571,000.00 |
| Other Receivables |
5,844,784,000.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
116,244,000.00 |
| Dividend Receivable |
33,095,000.00 |
| Inventories |
35,649,324,000.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
2,881,126,000.00 |
| Other Current Assets |
22,503,561,000.00 |
| Total Current Assets |
197,626,550,000.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
3,228,426,000.00 |
| Long-term Equity Investment |
11,360,606,000.00 |
| Investment Properties |
638,342,000.00 |
| Fixed Assetes |
20,355,736,000.00 |
| Under-construction Projects |
3,771,684,000.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
12,497,253,000.00 |
| R&D expenses |
45,741,000.00 |
| Goodwill |
3,304,258,000.00 |
| Long-Term Deferred and Prepaid Expenses |
542,469,000.00 |
| Deferred Income Tax Assets |
7,721,448,000.00 |
| Other Non-Current Assets |
13,353,798,000.00 |
| Sub-Total of Non-Current Assets |
89,511,556,000.00 |
| Total Assets |
287,138,106,000.00 |
| Short-Term Loans |
8,639,623,000.00 |
| Trading Financial liabilities |
31,536,000.00 |
| Notes Payable |
15,275,403,000.00 |
| Accounts Payable |
57,084,639,000.00 |
| Accounts Received In Advance |
844,029,000.00 |
| Employee Compensation Payable |
4,004,745,000.00 |
| Taxes Payable |
1,194,688,000.00 |
| Interest Payable |
323,653,000.00 |
| Dividend Payable |
229,570,000.00 |
| Other payables |
7,223,610,000.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
9,691,905,000.00 |
| Other Current Liabilities |
11,557,363,000.00 |
| Sub-Total of Current Liabilities |
160,814,075,000.00 |
| Long-term Loans |
23,027,281,000.00 |
| Bonds Payable |
748,844,000.00 |
| Long-Term Accounts Payable |
609,075,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
3,443,359,000.00 |
| Deferred Income Tax Liabilities |
840,508,000.00 |
| Other Non-Current Liabilities |
154,548,000.00 |
| Sub-Total of Non-Current Liabilities |
31,580,555,000.00 |
| Total Liabilities |
192,394,630,000.00 |
| Paid-In Capital(Or Share Stock) |
15,579,809,000.00 |
| Capital Surplus |
21,837,822,000.00 |
| Surplus Reserve |
5,906,524,000.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
11,786,116,000.00 |
| Minority Stockholder's Interest |
39,574,850,000.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
55,168,626,000.00 |
| Owner's Equity（Stockholder's Equity） |
94,743,476,000.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
287,138,106,000.00 |
